Oncothyreon to Present at Wedbush Securities Life Sciences Management Access
SEATTLE, Aug. 6, 2013
SEATTLE, Aug. 6, 2013 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) announced
today that Julie Eastland, Chief Financial Officer and Vice President,
Corporate Development, will present at the Wedbush Securities Life Sciences
Management Access Conference in New York on Tuesday, Aug. 13, 2013 at 1:55
A live and archived webcast of the presentation will be accessible by visiting
the Oncothyreon website www.oncothyreon.com under the "News & Events" section.
Oncothyreon is a biotechnology company specializing in the development of
innovative therapeutic products for the treatment of cancer. Oncothyreon's
goal is to develop and commercialize novel synthetic vaccines and targeted
small molecules that have the potential to improve the lives and outcomes of
cancer patients. For more information, visit www.oncothyreon.com.
SOURCE Oncothyreon Inc.
Investor and Media Relations Contact:
Press spacebar to pause and continue. Press esc to stop.